Cargando…
The Anticancer Agent Elesclomol Has Direct Effects on Mitochondrial Bioenergetic Function in Isolated Mammalian Mitochondria
Elesclomol ((N-malonyl-bis(N′-methyl-N′-thiobenzoylhydrazide)); formerly STA-4783) is a mitochondria-targeted chemotherapeutic agent that has demonstrated efficacy in selective cancer cell killing in pre-clinical and clinical testing. The biologically active form of elesclomol is a deprotonated copp...
Autores principales: | Modica-Napolitano, Josephine S., Bharath, Leena P., Hanlon, Alison J., Hurley, Liam D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724019/ https://www.ncbi.nlm.nih.gov/pubmed/31344923 http://dx.doi.org/10.3390/biom9080298 |
Ejemplares similares
-
Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-Targeted Anticancer Agents
por: Modica-Napolitano, Josephine S., et al.
Publicado: (2015) -
Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications
por: Tarin, Mojtaba, et al.
Publicado: (2023) -
Elesclomol restores mitochondrial function in genetic models of copper deficiency
por: Soma, Shivatheja, et al.
Publicado: (2018) -
Novel insights into anticancer mechanisms of elesclomol: More than a prooxidant drug
por: Gao, Jialing, et al.
Publicado: (2023) -
Mitochondrial Electron Transport Is the Cellular Target of the Oncology Drug Elesclomol
por: Blackman, Ronald K., et al.
Publicado: (2012)